HY-0102 Monotherapy in Patients With Locally Advanced/Metastatic Solid Tumours
Clinical trial NCT04914351 · COMPLETED
Trial details
- NCT number
- NCT04914351
- Sponsor
- Shanghai HyaMab Biotech Co.,Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-03
- Primary completion
- 2023-11-27
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.